Chemoinformaics analysis of 7-HYDROXY-3,6-DIMETHOXY-9-PHENYLPHENANTHRENE-1,4-DIONE
| Molecular Weight | 360.365 | nRot | 3 |
| Heavy Atom Molecular Weight | 344.237 | nRig | 24 |
| Exact Molecular Weight | 360.1 | nRing | 4 |
| Solubility: LogS | -6.206 | nHRing | 0 |
| Solubility: LogP | 3.926 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 3 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 51.4187 |
| nHD | 1 | BPOL | 21.2593 |
| QED | 0.76 |
| Synth | 2.44 |
| Natural Product Likeliness | 1.343 |
| NR-PPAR-gamma | 0.797 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.1 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.989 |
| MDCK | 0.0000252 |
| BBB | 0.078 |
| PPB | 0.981955 |
| VDSS | 0.377 |
| FU | 0.014254 |
| CYP1A2-inh | 0.957 |
| CYP1A2-sub | 0.82 |
| CYP2c19-inh | 0.958 |
| CYP2c19-sub | 0.07 |
| CYP2c9-inh | 0.902 |
| CYP2c9-sub | 0.862 |
| CYP2d6-inh | 0.872 |
| CYP2d6-sub | 0.408 |
| CYP3a4-inh | 0.848 |
| CYP3a4-sub | 0.17 |
| CL | 4.801 |
| T12 | 0.179 |
| hERG | 0.144 |
| Ames | 0.893 |
| ROA | 0.548 |
| SkinSen | 0.891 |
| Carcinogencity | 0.877 |
| EI | 0.684 |
| Respiratory | 0.479 |
| NR-Aromatase | 0.825 |
| Antiviral | Yes |
| Prediction | 0.840834 |